CCL17 and esophageal squamous cell carcinoma: In this work, for functional experiments, Eca109 cells cultivated in M2-CM were treated with anti-IgG (50 μg/ml) or anti-CCL17 (50 μg/ml) to expound the tumor-promoting effects of M2-like macrophage-derived CCL17 in ESCC.